Risk of a global economic downturn due to the spread of the novel coronavirus
First written in FY2020-Q3. 4 of 10 entries say "Restated". Latest entry: FY2024-Q2.
Kaneka moved to the "Worse" side of this theme in 2020, the same year as the typical company in this theme.
The whole theme swung hardest in 2019: 13 of 36 companies on the "Worse" side.
0 other companies' latest entry also says "Mitigated".
- FY2024-Q2MitigatedAnnual report
「Pharma was affected by the easing of the COVID-19 pandemic and inventory adjustments by customers.」
Regarding business-environment risk from the spread of COVID-19, the company states that the pandemic has subsided, indicating that its impact is easing from the previous phase of widespread infections. However, customer inventory adjustments remain. - FY2023-Q2MitigatedAnnual report
「During the six months ended 30 September, the global economy remained unstable. While the social impact of COVID-19 was easing, the situation in Ukraine remained confused, energy and raw material prices rose and fell sharply, and the economy slowed as global inflation accelerated and interest rates rose, amid a substantial depreciation of the yen.」
While stating that the social impact of COVID-19 is easing, the company identifies other sources of uncertainty, including the situation in Ukraine and inflation. - FY2023-Q1MitigatedAnnual report
「During the three months ended 30 June 2022, the global economy experienced a gradual recovery as society moved toward normalization with the easing of the COVID-19 situation.」
Regarding downside risk to the global economy from the spread of COVID-19, the company describes the easing of the pandemic and the normalization of society. At the same time, other sources of uncertainty, including the situation in Ukraine and inflation, have increased. - FY2022-Q3RestatedAnnual report
「However, shortages of components and materials, including semiconductors, logistical disruption, and elevated resource and energy prices have continued. The business environment remains uncertain due to the impact of renewed COVID-19 infections on production activity and rising prices.」
While acknowledging the recovery trend in the economy, the company continues to identify shortages of components and materials, logistics disruption, higher resource and energy prices, and renewed infections as sources of uncertainty. - FY2022-Q2RestatedAnnual report
「Global Economic Conditions During the six months ended 30 September 2021, the global economy remained uncertain due to the renewed spread of COVID-19, but economic activity steadily picked up and entered a recovery trend, supported by economic policies and monetary easing in各国.」
The company continues to describe uncertainty caused by the renewed spread of COVID-19 while acknowledging the recovery trend in economic activity. - FY2022-Q1WorsenedAnnual report
「However, recovery momentum by industry remains fragile in emerging regions, while global supply-chain disruption, represented by semiconductor shortages, and difficulty securing export shipping capacity in Asia are hindering the recovery. With variant strains causing renewed outbreaks in countries around the world, the outlook for the global economy is becoming increasingly uncertain.」
While the global economy is on a recovery trend, uncertainty is increasing due to renewed outbreaks of variant strains, and factors hampering the recovery continue to persist. - FY2021RestatedAnnual report
「However, if a renewed global spread of infectious disease or a similar event occurs, disruption to the supply chain could adversely affect the financial position, operating results and cash flows of the Group.」
Even after the impact of COVID-19 actually emerged, the company explicitly identified disruption to the global supply chain caused by a renewed spread of infectious disease as a major risk. - FY2021-Q3RestatedAnnual report
「Economic activity generally recovered from the bottom reached in the first quarter through the second quarter (July to September 2020, hereinafter the “second quarter”) and the third quarter (October to December 2020, hereinafter the “third quarter”). However, the renewed spread of COVID-19 remains a source of concern, with Europe returning to negative growth in the third quarter compared with the second quarter.」
While economic activity entered a recovery trend from the first quarter, negative growth in Europe and the renewed spread of COVID-19 remain sources of concern. - FY2021-Q1MaterialisedAnnual report
「The first quarter of the current fiscal year (1 April 2020 to 30 June 2020, hereinafter the “current period”) was severely affected by the explosive spread of the novel coronavirus pandemic. As fear of COVID-19 spread worldwide, economic activity in every industry sector was forced to contract substantially, in an unprecedented situation approaching a near-total halt.」
Regarding the downside risk from COVID-19 identified as a concern in the previous quarter, the company states that a contraction in economic activity across all industries and a severe impact on its own performance actually occurred. - FY2020-Q3First statedAnnual report
「Concerns about downside risk from the spread of the novel coronavirus that began in January are expanding at an unexpected pace. The situation could have a serious impact on the global economy.」
The company has identified downside risk to the global economy from the spread of COVID-19 as a new external risk.